Phase 1 Study Of The Antibody-Drug Conjugate Sgn-Liv1a In Patients With Heavily Pretreated Triple-Negative Metastatic Breast Cancer

CANCER RESEARCH(2018)

Cited 60|Views13
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined